• 1
    Minna JD. Neoplasms of the lung. In: FauciA, BraunwaldE, KasperD, HauserS, LongoD, JamesonJ (eds). Harrison's principles of internal medicine, 15th edn. McGraw-Hill, New York 2001; 56271.
  • 2
    Statistics and Information Department, Minister's Secretariat. Vital statistics of Japan 2001, Vol. 3. Ministry of Health, Labor and Welfare, Tokyo 2003; 384–411.
  • 3
    Osada H, Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002; 21: 742134.
  • 4
    Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Reduced expression of the let-7 microRNA in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 37536.
  • 5
    Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 155249.
  • 6
    Michael MZ, Sm OC, Van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNA in colorectal neoplasia. Mol Cancer Res 2003; 1: 88291.
  • 7
    Ambros V. MicroRNA pathways in flies and worms. growth, death, fat, stress, and timing. Cell 2003; 113: 6736.
  • 8
    Bartel DP. MicroRNA: genomics, biogenesis mechanism and function. Cell 2004; 116: 28197.
  • 9
    Grosshans H, Slack FJ. Micro-RNA: small is plentiful. J Cell Biol 2002; 156: 1721.
  • 10
    Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 4159.
  • 11
    Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293: 8348.
  • 12
    Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 3636.
  • 13
    Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNA that control C. elegans developmental timing. Cell 2001; 106: 2334.
  • 14
    Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001; 15: 26549.
  • 15
    Knight SW, Bass BL. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 2001; 293: 226971.
  • 16
    Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. Embo J 2002; 21: 466370.
  • 17
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T. Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines. Cancer Res 2001; 61: 83319.
  • 18
    Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 621.
  • 19
    Abujiang P, Mori TJ, Takahashi T, Tanaka F, Kasyu I, Hitomi S, Hiai H. Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 1998; 17: 302933.
  • 20
    Wong MP, Lam WK, Wang E, Chiu SW, Lam CL, Chung LP. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. Cancer Res 2002; 62: 44648.
  • 21
    Suzuki T, Yokota J, Mugishima H, Okabe I, Ookuni M, Sugimura T, Terada M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 1989; 49: 10958.
  • 22
    Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB. Human epithelial ovarian cancer allelotype. Cancer Res 1993; 53: 23938.
  • 23
    Nawroz H, Van Der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994; 54: 11525.
  • 24
    Chang WY, Cairns P, Schoenberg MP, Polascik TJ, Sidransky D. Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 1995; 55: 32469.
  • 25
    Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 1997; 19: 2935.
  • 26
    De Rienzo A, Jhanwar SC, Testa JR. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma. Genes Chromosomes Cancer 2000; 28: 33741.
  • 27
    Young J, Leggett B, Ward M, Thomas L, Buttenshaw R, Searle J, Chenevix-Trench G. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene 1993; 8: 6715.
  • 28
    Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002; 297: 18337.
  • 29
    Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI. Establishment and maintenance of a heterochromatin domain. Science 2002; 297: 22327.
  • 30
    Provost P, Silverstein RA, Dishart D, Walfridsson J, Djupedal I, Kniola B, Wright A, Samuelsson B, Radmark O, Ekwall K. Dicer is required for chromosome segregation and gene silencing in fission yeast cells. Proc Natl Acad Sci U S A 2002; 99: 1664853.
  • 31
    Hall IM, Noma K, Grewal SI. RNA interference machinery regulates chromosome dynamics during mitosis and meiosis in fission yeast. Proc Natl Acad Sci U S A 2003; 100: 1938.
  • 32
    Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, Allshire RC. RNA interference is required for normal centromere function in fission yeast. Chromosome Res 2003; 11: 13746.
  • 33
    Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002; 21: 688497.
  • 34
    Haruki N, Harano T, Masuda A, Kiyono T, Takahashi T, Tatematsu Y, Shimizu S, Mitsudomi T, Konishi H, Osada H, Fujii Y, Takahashi T. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol 2001; 159: 134552.
  • 35
    Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S, Osada H, Takahashi T. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene 1999; 18: 4295300.
  • 36
    Suzuki H, Ueda R, Takahashi T. Altered imprinting in lung cancer. Nat Genet 1994; 6: 3323.
  • 37
    Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 1995; 10: 11938.